|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
80.300 +2.550 (+3.280%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (712,407) | (789,634) | (303,620) | (401,934) |
| Net Cash from / (used in) Investing Activities | -- | 39,075 | 67,708 | 468,203 | (645,586) |
| Net Cash from / (used in) Financing Activities | -- | 788,720 | 283,898 | 72,131 | (8,059) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 115,388 | (438,028) | 236,714 | (1,055,579) |
| Cash & Cash Equivalents at beginning of period | -- | 418,413 | 851,029 | 604,070 | 1,520,619 |
| Effect of Foreign Exchange Rate Changes | -- | (30,456) | 5,412 | 10,245 | 139,030 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 503,345 | 418,413 | 851,029 | 604,070 |
| Remarks: | Real time quote last updated: 21/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,217,447 |
| %Change | -- |
| EPS / (LPS) | RMB 4.290 |
| NBV Per Share (¥) | RMB 13.409 |